A new study shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high rates of typhoid fever in resource-limited settings.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200917084052.htm
No comments:
Post a Comment